Compare WST & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WST | KB |
|---|---|---|
| Founded | 1923 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9B | 31.3B |
| IPO Year | 2004 | 2008 |
| Metric | WST | KB |
|---|---|---|
| Price | $245.08 | $97.49 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $319.43 | N/A |
| AVG Volume (30 Days) | ★ 790.6K | 264.3K |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | 0.36% | ★ 1.58% |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 6.79 | N/A |
| Revenue | ★ $2,886,900,000.00 | N/A |
| Revenue This Year | $6.76 | $17.35 |
| Revenue Next Year | $6.15 | $3.15 |
| P/E Ratio | $35.86 | ★ $9.90 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $187.43 | $46.38 |
| 52 Week High | $322.34 | $119.71 |
| Indicator | WST | KB |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 39.32 |
| Support Level | $239.86 | $97.21 |
| Resistance Level | $251.73 | $100.19 |
| Average True Range (ATR) | 6.47 | 2.62 |
| MACD | 1.03 | -0.57 |
| Stochastic Oscillator | 65.68 | 13.48 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.